Federal Antimonopoly Service warns: the Chinese druggists need to know rules of pricing to Russian Federation

from 800 vital major medicines 51 positions are presented to Russian Federation. At the Russian-Chinese forum of Federal Antimonopoly Service paid attention of partners to features of pricing, reports information agency "ITAR-TASS". Timofey Nizhegorodtsev, the deputy head of Federal Antimonopoly Service, in performance at the Russian-Chinese pharmaceutical forum which takes place in Shanghai, paid attention that companies from China, entering the Russian market, have to know features of pricing to Russian Federation. They need to consider the operating mechanism of establishment of the prices...